GlassScriptPhysician profile
Kayla M Kimble
NPI 1811778343
$1,108.33
in general payments reported to CMS, 2019-2025
20 companies · $42.52 in 2025
The $42.52 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $97.76 · 2024: $968 · 2025: $42.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $250.04 | 2024 | Farxiga, Airsupra, Breztri |
| Genzyme Corporation | $105.39 | 2024 | |
| Mylan Specialty L.P. | $99.08 | 2024 | Yupelri |
| Abbvie INC. | $92.23 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $82.64 | 2024 | Dupixent |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $81.38 | 2023-2024 | Caplyta |
| Lundbeck LLC | $63.69 | 2023-2024 | Rexulti |
| Boston Scientific Corporation | $62.16 | 2024-2025 | Varithena Administration Pack |
| Lilly USA, LLC | $41.40 | 2024 | Mounjaro, Zepbound |
| United Therapeutics Corporation | $30.30 | 2024 | Tyvaso |
| Amgen INC. | $29.26 | 2024 | Repatha, Otezla |
| Actelion Pharmaceuticals US, INC. | $25.05 | 2023 | Uptravi, Opsumit |
| Mallinckrodt Hospital Products INC. | $24.03 | 2024 | Acthar |
| Novo Nordisk INC | $21.62 | 2024 | Wegovy |
| Insmed, INC. | $21.22 | 2024 | Arikayce |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.15 | 2024 | Xolair |
| Inogen, INC. | $16.24 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Takeda Pharmaceuticals U.S.A., INC. | $16.21 | 2024 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $14.71 | 2024 | |
| Exact Sciences Corporation | $14.53 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Kimble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.